Suppr超能文献

乳腺癌中HER-2/neu癌基因表达及DNA倍体分析

HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.

作者信息

Bacus S S, Bacus J W, Slamon D J, Press M F

机构信息

Cell Analysis Systems, Inc, Lombard, IL 60126-4944.

出版信息

Arch Pathol Lab Med. 1990 Feb;114(2):164-9.

PMID:1967930
Abstract

This study was performed to evaluate the correlation between HER-2/neu gene expression and DNA ploidy patterns. Forty-five cases of breast-cancer were analyzed. Immunohistochemical staining of HER-2/neu protein on frozen sections was used to detect the HER-2/neu protein, and the Feulgen DNA staining method was used to assess DNA amounts in the same tumor cells. Positive HER-2/neu overexpression was evaluated visually, and quantitation of the HER-2/neu protein was measured by image analysis. Twenty-two of the 45 cases were visually scored to be positive for the overexpression of the HER-2/neu protein, and these cases also contained above 10% HER-2/neu protein compared with a standard control cell line. All 22 of these cases had near-tetraploid DNA content. In contrast, cells, derived from the 23 cases that did not overexpress the HER-2/neu protein, contained DNA amounts that ranged from euploid (diploid) to varying degrees of aneuploid. The results of this study indicated that tumors that overexpress the HER-2/neu protein have tetraploid or near-tetraploid DNA content. This pattern could relate to the biological behavior of these tumors.

摘要

本研究旨在评估HER-2/neu基因表达与DNA倍体模式之间的相关性。对45例乳腺癌病例进行了分析。采用冷冻切片上HER-2/neu蛋白的免疫组织化学染色来检测HER-2/neu蛋白,同时使用福尔根DNA染色法评估同一肿瘤细胞中的DNA含量。通过视觉评估HER-2/neu的阳性过表达情况,并通过图像分析对HER-2/neu蛋白进行定量测定。45例病例中有22例在视觉上被判定为HER-2/neu蛋白过表达阳性,与标准对照细胞系相比,这些病例中HER-2/neu蛋白含量也超过10%。所有这22例病例的DNA含量均接近四倍体。相比之下,来自23例未过表达HER-2/neu蛋白病例的细胞,其DNA含量范围从整倍体(二倍体)到不同程度的非整倍体。本研究结果表明,过表达HER-2/neu蛋白的肿瘤具有四倍体或接近四倍体的DNA含量。这种模式可能与这些肿瘤的生物学行为有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验